Condensed Consolidated Statements of Earnings (unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
Net Sales	$ 1,847.4	$ 1,783.8
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember
Cost of products sold, excluding intangible asset amortization	$ 516.4	$ 487.1
Type of Cost, Good or Service [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember
Intangible asset amortization	$ 155.5	$ 147.6
Research and development	94.4	98.4
Selling, general and administrative	770.1	828.9
Goodwill impairment		612.0
Restructuring and other cost reduction initiatives	21.8	45.0
Quality remediation	10.2	16.4
Acquisition, integration, divestiture and related	13.4	4.4
Operating expenses	1,581.8	2,239.8
Operating Profit (Loss)	265.6	(456.0)
Other income, net	7.3	3.0
Interest expense, net	(52.3)	(50.9)
Earnings (loss) before income taxes	220.6	(503.9)
Provision for income taxes	22.9	5.2
Net Earnings (Loss)	197.7	(509.1)
Less: Net loss attributable to noncontrolling interest	(0.4)	(0.6)
Net Earnings (Loss) of Zimmer Biomet Holdings, Inc.	$ 198.1	$ (508.5)
Earnings (Loss) Per Common Share
Basic	$ 0.95	$ (2.46)
Diluted	$ 0.94	$ (2.46)
Weighted Average Common Shares Outstanding
Basic	208.0	206.5
Diluted	210.2	206.5